Figure 3.

Distribution (%) of the number of ADs dispensed any time prior to the treatment start among incident treatments. Legend: AGI = alpha-glucosidase inhibitors; DPP4i = dipeptidyl peptidase-4 inhibitors; GLP-1RA = glucagon-like peptide-1 receptor antagonists; SGLT2i = sodium–glucose linked transporter 2 inhibitors; Other oral combinations = fixed-dose combinations of glitazones + DPP4i and glitazones + sulfonylureas. Only number of ATCs belonging to a different antidiabetic molecule/class as compared to the molecule/class that was dispensed at the index date.